Phase 4 Osteoarthritis Trial, Recruiting NCT07217405 Sponsor: Mayo Clinic Condition: Osteoarthritis
Back to Osteoarthritis

Phase 4 Osteoarthritis Trial, Recruiting

NCT07217405
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a patient at Mayo Clinic in Rochester, MN
  • You are 50 years old or older
  • You have been diagnosed with mild, moderate, or severe hand osteoarthritis, confirmed by an X-ray taken within the last 2 years
  • You experience hand pain of at least 40 out of 100 on a pain scale when using the affected hand
  • You are able to fill out study questionnaires on your own

Who may not be able to join:

  • You have had surgery on the affected hand in the past
  • You have an autoimmune joint disease, such as rheumatoid arthritis or psoriatic arthritis
  • You have another active hand condition, such as trigger finger or Dupuytren's contracture (a condition that causes fingers to bend toward the palm)
  • You injured the affected hand within the last month and are still in pain from that injury
  • You have had a gout or pseudogout flare-up in the affected hand
  • You have used strong opioid pain medicines or steroid tablets in the last 3 months
  • You have fibromyalgia or a condition called central sensitization syndrome (confirm with trial site)
  • You have had an injection into your hand within the last 3 months
  • You have had a specific type of low-dose radiation treatment to the hand within the last 3 months (confirm with trial site)
  • You have poorly controlled diabetes, based on a blood test result above a certain level (confirm with trial site)
  • You currently have an active infection
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Terin Sytsma, MD, Mayo Clinic

Phone: (507) 422-3201

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Registry
ClinicalTrials.gov
Start date
19 December 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Visual Analog Scale (VAS) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov